Suraksha Diagnostic Limited IPO: Everything You Need to Know
Introduction:
Suraksha Diagnostic Limited’s IPO is one of the highly anticipated offerings of 2024. As a fintech platform, Tap Invest aims to inform you about lucrative investment opportunities, such as bonds and IPOs, to diversify your portfolio. This IPO is a book-built issue worth ₹846.25 crores, consisting entirely of an Offer for Sale (OFS) of 1.92 crore shares.
This article will explain the key details of the Suraksha Diagnostic IPO, including its timeline, price band, strengths, and investment strategies.
Suraksha Diagnostic IPO: Key Details
| IPO Details | Specifications |
| IPO Date | November 29, 2024 – December 3, 2024 |
| Listing Date | December 6, 2024 (Tentative) |
| Face Value | ₹2 per share |
| Price Band | ₹420 to ₹441 per share |
| Lot Size | 34 shares |
| Total Issue Size | ₹846.25 Cr |
| Offer for Sale (OFS) | 1.92 crore shares |
| Listing Platforms | BSE, NSE |
Reservation Details:
| Investor Category | Shares Offered |
| Qualified Institutional Buyers (QIB) | Not more than 50% of the Net Offer |
| Retail Investors | Not less than 35% of the Net Offer |
| Non-Institutional Investors (NII) | Not less than 15% of the Net Offer |
IPO Timeline:
| Event | Date |
| IPO Open Date | November 29, 2024 |
| IPO Close Date | December 3, 2024 |
| Basis of Allotment Finalization | December 4, 2024 |
| Initiation of Refunds | December 5, 2024 |
| Credit of Shares to Demat | December 5, 2024 |
| Listing Date | December 6, 2024 |
Lot Size and Investment Details:
Investors can apply for a minimum of 34 shares, with the below table summarising investment requirements:
| Investor Type | Lots | Shares | Investment Amount |
| Retail (Min) | 1 | 34 | ₹14,994 |
| Retail (Max) | 13 | 442 | ₹194,922 |
| sNII (Min) | 14 | 476 | ₹209,916 |
| bNII (Min) | 67 | 2,278 | ₹1,004,598 |
About Suraksha Diagnostic Limited:
Founded in 2005, Suraksha Diagnostic Limited offers a comprehensive suite of diagnostic services, including pathology, radiology, and medical consultations. With a stronghold in eastern and northeastern India, the company has:
- A central reference laboratory,
- 8 satellite laboratories,
- 215 customer touchpoints, including 49 diagnostic centres and 166 sample collection centres.
Key Highlights:
- Technological Edge:
- Use of Laboratory Information Management Systems (LIMS).
- Digital pathology and AI-powered blood testing.
- Radiology Information Systems (RIS) and Picture Archive Communication Systems (PACS).
- Comprehensive Services:
- Vaccination programs.
- Customised health testing packages.
- Single-source solutions for pathology and radiology services.
- Strong Market Position:
- A recognised leader in the fragmented diagnostics market of eastern India.
- High customer retention rates supported by quality and technology-driven services.
Why Consider Suraksha Diagnostic IPO?
- Strong Industry Growth Potential:
India’s diagnostic sector is rapidly expanding due to increasing health awareness, and Suraksha Diagnostics is well-poised to benefit from this growth. - Technology-Driven Operations:
Adopting cutting-edge diagnostic tools ensures efficient services, reduced turnaround times, and higher customer satisfaction. - Portfolio Diversification:
Investing in IPOs like Suraksha Diagnostic allows retail investors to diversify beyond traditional fixed-income instruments.
For a detailed comparison between IPOs and Offer for Sale (OFS), check out our article on OFS vs IPO Differences.
Suraksha Diagnostic IPO Price Band Analysis:
The price band of ₹420 to ₹441 per share makes this IPO attractive for retail and institutional investors. With a minimum investment of ₹14,994 for 34 shares, the IPO suits a range of budgets.
Explore our insights on IPO Grey Market Premium (GMP) to better understand pricing strategies and market premiums.
Investment Strategies:
1. Retail Investors:
- Apply for a single or up to 13 lots based on your risk appetite and budget.
- It is ideal for diversifying portfolios with moderate exposure to diagnostics and healthcare.
2. HNIs and Institutional Investors:
- High net-worth individuals (HNIs) should leverage sNII and bNII categories for larger allotments.
- Institutional investors can benefit from long-term growth potential.
If you’re considering short-term gains through IPO flipping, learn more in our guide to IPO Flipping.
FAQs On Suraksha Diagnostic IPO:
1. What is the Suraksha Diagnostic IPO price band?
The price band is set between ₹420 and ₹441 per share.
2. When will the Suraksha Diagnostic IPO open and close?
The IPO opens on November 29, 2024, and closes on December 3, 2024.
3. What is the minimum investment for retail investors?
The minimum investment is ₹14,994 for 34 shares.
4. What type of issue is the Suraksha Diagnostic IPO?
It is a Book Built Issue IPO and an Offer for Sale (OFS).
5. Where will the shares be listed?
The shares will be listed on BSE and NSE.
Conclusion:
The Suraksha Diagnostic Limited IPO offers an exciting opportunity to invest in a growing diagnostics chain with a solid technological backbone. Whether you’re looking for short-term flipping or long-term portfolio diversification, this IPO is worth considering. For more updates and investment insights, visit our blog at Tap Invest.
